We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-13.83%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.51B
AUM Growth
-$1.01B
Cap. Flow
+$139M
Cap. Flow %
2.14%
Top 10 Hldgs %
20.49%
Holding
891
New
87
Increased
331
Reduced
275
Closed
84

Top Sells

Rank Stock Value
1
TSRO
TESARO, Inc.
TSRO
+$32.8M
2
EC icon
Ecopetrol
EC
+$29.1M
3
AET
Aetna Inc
AET
+$20.2M
4
XOM icon
ExxonMobil
XOM
+$19.6M
5
AMGN icon
Amgen
AMGN
+$19.2M

Sector Composition

Rank Sector Weight
1 Healthcare 35.31%
2 Technology 15.37%
3 Financials 11.61%
4 Consumer Discretionary 8.19%
5 Communication Services 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VZ icon
26
Verizon
VZ
$194B
$45.8M 0.7%
815,565
-43,750
-5% -$2.48M
ABT icon
27
Abbott
ABT
$180B
$44.3M 0.68%
612,644
+28,026
+5% +$1.97M
DHR icon
28
Danaher
DHR
$135B
$43M 0.66%
470,730
-11,286
-2% -$1.02M
BRK.B icon
29
Berkshire Hathaway Class B
BRK.B
$1.07T
$42.9M 0.66%
210,319
+1,945
+0.9% +$406K
CSCO icon
30
Cisco
CSCO
$450B
$42M 0.65%
969,065
-118,257
-11% -$5.41M
T icon
31
AT&T
T
$165B
$40.6M 0.62%
1,883,526
-13,582
-0.7% -$316K
PYPL icon
32
PayPal
PYPL
$49.5B
$40.3M 0.62%
479,321
+143,094
+43% +$11.9M
BMRN icon
33
BioMarin Pharmaceuticals
BMRN
$11.5B
$39.2M 0.6%
459,852
+55,859
+14% +$5.31M
INTC icon
34
Intel
INTC
$466B
$38.8M 0.6%
826,810
+355,670
+75% +$16.7M
CRM icon
35
Salesforce
CRM
$134B
$37.4M 0.58%
273,304
+32,746
+14% +$4.5M
ORCL icon
36
Oracle
ORCL
$331B
$36.5M 0.56%
809,243
-315,157
-28% -$15.1M
GOOG icon
37
Alphabet (Google) Class C
GOOG
$3.9T
$35.9M 0.55%
692,940
+56,800
+9% +$3.04M
AXP icon
38
American Express
AXP
$223B
$34.5M 0.53%
362,008
-16,356
-4% -$1.71M
AMAT icon
39
Applied Materials
AMAT
$426B
$33.2M 0.51%
1,014,367
+181,212
+22% +$6.21M
ADBE icon
40
Adobe
ADBE
$89.5B
$33.2M 0.51%
146,585
+35,903
+32% +$8.67M
AVGO icon
41
Broadcom
AVGO
$1.82T
$31.7M 0.49%
1,245,840
+151,600
+14% +$3.58M
ROK icon
42
Rockwell Automation
ROK
$51.4B
$31.3M 0.48%
207,748
+18,889
+10% +$3.15M
CMCSA icon
43
Comcast
CMCSA
$79.1B
$30.9M 0.48%
908,404
-41,747
-4% -$1.52M
MA icon
44
Mastercard
MA
$477B
$30.3M 0.47%
160,427
+94,006
+142% +$18.7M
C icon
45
Citigroup
C
$222B
$30.2M 0.46%
579,545
+62,890
+12% +$3.98M
A icon
46
Agilent Technologies
A
$39.1B
$30.1M 0.46%
445,858
-220,244
-33% -$14.8M
INCY icon
47
Incyte
INCY
$23.5B
$29.6M 0.45%
465,522
+149,727
+47% +$9.72M
MKC icon
48
McCormick & Company Non-Voting
MKC
$13.4B
$29.1M 0.45%
418,432
-18,696
-4% -$1.34M
LOXO
49
DELISTED
Loxo Oncology, Inc
LOXO
$28.1M 0.43%
200,673
+63,131
+46% +$9.58M
IBM icon
50
IBM
IBM
$202B
$24.7M 0.38%
227,116
+15,262
+7% +$1.83M

Similar funds

Candriam SCA's Q4 2018 Portfolio in Review

As of Q4 2018, Candriam SCA held 891 positions worth $6.51B, down 13% from $7.52B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q4 2018 filing shows 87 new, 331 increased, 275 reduced and 84 closed positions. Its largest new stake was Azul: 501,000 shares worth $13.9M. The largest sale was TESARO, Inc., an estimated $32.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2018 buy was Azul: 501,000 shares worth $13.9M.
  • Candriam SCA added most to Celgene Corp in Q4 2018, an estimated $60.9M increase.
  • Candriam SCA's biggest Q4 2018 reduction was TESARO, Inc., cutting an estimated $32.8M.
  • Candriam SCA fully exited Aetna Inc in Q4 2018, selling an estimated $20.2M.
  • Candriam SCA's ten largest holdings make up 20% of its $6.51B portfolio in Q4 2018.
  • Candriam SCA opened 87 new positions and closed 84 in Q4 2018.
  • Candriam SCA's portfolio value fell 13% quarter-over-quarter to $6.51B.

Based on Candriam SCA's 13F filing for Q4 2018, filed 14 Feb 2019.